| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kazuko Sakata, Joshua R Mastin, Sean M Duke, Meghan G Vail, Abigail E Overacre, Brittany E Dong, Shanker Jh. Effects of antidepressant treatment on mice lacking brain-derived neurotrophic factor expression through promoter IV. The European journal of neuroscience. vol 37. issue 11. 2013-12-12. PMID:23406189. |
brain-derived neurotrophic factor (bdnf) is implicated in the pathophysiology of major depression; mice lacking bdnf expression through promoter iv (bdnf-kiv) exhibit a depression-like phenotype. |
2013-12-12 |
2023-08-12 |
mouse |
| Mohammad Haghighi, Iraj Salehi, Parichehr Erfani, Leila Jahangard, Hafez Bajoghli, Edith Holsboer-Trachsler, Serge Bran. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. Journal of psychiatric research. vol 47. issue 7. 2013-12-09. PMID:23583029. |
the aim of the present study was therefore to assess plasma bdnf levels and depression of patients suffering from severe mdd treated with additional ect compared to patients treated with citalopram only. |
2013-12-09 |
2023-08-12 |
Not clear |
| Lindsey B Stone, John E McGeary, Rohan H C Palmer, Brandon E Gib. Identifying genetic predictors of depression risk: 5-HTTLPR and BDNF Val66Met polymorphisms are associated with rumination and co-rumination in adolescents. Frontiers in genetics. vol 4. 2013-12-06. PMID:24312122. |
identifying genetic predictors of depression risk: 5-httlpr and bdnf val66met polymorphisms are associated with rumination and co-rumination in adolescents. |
2013-12-06 |
2023-08-12 |
Not clear |
| Valeriya Avdoshina, Italo Mocchetti, Chenglong Liu, Mary A Young, Kathryn Anastos, Mardge Cohen, Howard Crystal, Celeste L Pearce, Elizabeth T Golub, Rochelle E Tractenber. Single-nucleotide polymorphisms in TrkB and risk for depression: findings from the women's interagency HIV study. Journal of acquired immune deficiency syndromes (1999). vol 64. issue 2. 2013-11-13. PMID:24047966. |
hiv lowers brain-derived neurotrophic factor (bdnf), a neurotrophic factor whose receptors play a crucial role in the pathophysiology of depression. |
2013-11-13 |
2023-08-12 |
human |
| Valeriya Avdoshina, Italo Mocchetti, Chenglong Liu, Mary A Young, Kathryn Anastos, Mardge Cohen, Howard Crystal, Celeste L Pearce, Elizabeth T Golub, Rochelle E Tractenber. Single-nucleotide polymorphisms in TrkB and risk for depression: findings from the women's interagency HIV study. Journal of acquired immune deficiency syndromes (1999). vol 64. issue 2. 2013-11-13. PMID:24047966. |
therefore, we examined whether a single-nucleotide polymorphism in the bdnf gene (rs56164415) and related receptors trkb (rs1212171) and p75 (rs2072446) were associated with depression in hiv-infected individuals. |
2013-11-13 |
2023-08-12 |
human |
| Teresa F Burke, Tushar Advani, Megumi Adachi, Lisa M Monteggia, Julie G Hensle. Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice. The international journal of neuropsychopharmacology. vol 16. issue 3. 2013-10-31. PMID:22575584. |
decreased brain-derived neurotrophic factor (bdnf) expression and/or function, particularly in hippocampus, are implicated in the pathophysiology of stress-related disorders such as major depression. |
2013-10-31 |
2023-08-12 |
mouse |
| Merja L Viikki, Kaija Järventausta, Esa Leinonen, Martti Huuhka, Nina Mononen, Terho Lehtimäki, Olli Kampma. BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression. Psychiatric genetics. vol 23. issue 3. 2013-10-23. PMID:23532066. |
bdnf polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression. |
2013-10-23 |
2023-08-12 |
Not clear |
| Merja L Viikki, Kaija Järventausta, Esa Leinonen, Martti Huuhka, Nina Mononen, Terho Lehtimäki, Olli Kampma. BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression. Psychiatric genetics. vol 23. issue 3. 2013-10-23. PMID:23532066. |
the aim of the present study was to test for a possible association between two brain-derived neurotrophic factor (bdnf) polymorphisms (rs11030101 and rs61888800) and the efficacy of electroconvulsive therapy (ect) [change in montgomery-Åsberg depression rating scale (madrs)]. |
2013-10-23 |
2023-08-12 |
Not clear |
| Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin, Carmine M Pariant. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 38. issue 3. 2013-10-17. PMID:22990943. |
in this study, we tested the leukocyte mrna expression levels of genes belonging to glucocorticoid receptor (gr) function (fkbp-4, fkbp-5, and gr), inflammation (interleukin (il)-1α, il-1β, il-4, il-6, il-7, il-8, il-10, macrophage inhibiting factor (mif), and tumor necrosis factor (tnf)-α), and neuroplasticity (brain-derived neurotrophic factor (bdnf), p11 and vgf), in healthy controls (n=34) and depressed patients (n=74), before and after 8 weeks of treatment with escitalopram or nortriptyline, as part of the genome-based therapeutic drugs for depression study. |
2013-10-17 |
2023-08-12 |
Not clear |
| Paolo Bosco, Raffaele Ferri, Maria Grazia Salluzzo, Sabrina Castellano, Maria Signorelli, Ferdinando Nicoletti, Santo Di Nuovo, Filippo Drago, Filippo Carac. Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment. Current genomics. vol 14. issue 2. 2013-10-01. PMID:24082824. |
genetic variations of neurotrophic factors, such as brain-derived neurotrophic factor (bdnf), and transforming-growth-factor-β1 (tgf-β1) are known to increase the risk to develop load and have also been related to depression susceptibility in load. |
2013-10-01 |
2023-08-12 |
Not clear |
| Ari Illi, Merja Viikki, Outi Poutanen, Eija Setälä-Soikkeli, Timo Nuolivirta, Olli Kampman, Esa Leinonen, Heini Huhtala, Nina Mononen, Terho Lehtimäk. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. Psychiatric genetics. vol 23. issue 1. 2013-09-20. PMID:23250003. |
brain-derived neurotrophic factor (bdnf) is suggested to play a role in the aetiology of major depression and in the antidepressant response in patients with major depression. |
2013-09-20 |
2023-08-12 |
Not clear |
| Ari Illi, Merja Viikki, Outi Poutanen, Eija Setälä-Soikkeli, Timo Nuolivirta, Olli Kampman, Esa Leinonen, Heini Huhtala, Nina Mononen, Terho Lehtimäk. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. Psychiatric genetics. vol 23. issue 1. 2013-09-20. PMID:23250003. |
the aim of the present study was to examine the role of two bdnf gene polymorphisms (rs11030101 and rs61888800) in relation to the response to selective serotonin reuptake inhibitor medication in 106 patients of finnish origin suffering from major depression. |
2013-09-20 |
2023-08-12 |
Not clear |
| Susan Ball, Lauren B Marangell, Sarah Lipsius, James M Russel. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial. Progress in neuro-psychopharmacology & biological psychiatry. vol 43. 2013-09-19. PMID:23313564. |
brain-derived neurotrophic factor (bdnf) has been implicated in the pathophysiology of depression and anxiety, but has not been examined systematically in generalized anxiety disorder (gad). |
2013-09-19 |
2023-08-12 |
Not clear |
| S Varambally, G H Naveen, M G Rao, J Thirthalli, R Sharma, R Christopher, B N Gangadha. Low serum brain derived neurotrophic factor in non-suicidal out-patients with depression: Relation to depression scores. Indian journal of psychiatry. vol 55. issue Suppl 3. 2013-09-19. PMID:24049207. |
low brain-derived neurotrophic factor (bdnf) has been implicated in the pathophysiology of depression. |
2013-09-19 |
2023-08-12 |
Not clear |
| S Varambally, G H Naveen, M G Rao, J Thirthalli, R Sharma, R Christopher, B N Gangadha. Low serum brain derived neurotrophic factor in non-suicidal out-patients with depression: Relation to depression scores. Indian journal of psychiatry. vol 55. issue Suppl 3. 2013-09-19. PMID:24049207. |
the relation between bdnf and severity of depression has been investigated. |
2013-09-19 |
2023-08-12 |
Not clear |
| Joseph P Gyekis, Weihong Yu, Shuqian Dong, Haina Wang, Jun Qian, Pravina Kota, Jingyun Yan. No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 162B. issue 1. 2013-09-16. PMID:23184535. |
no association of genetic variants in bdnf with major depression: a meta- and gene-based analysis. |
2013-09-16 |
2023-08-12 |
Not clear |
| Joseph P Gyekis, Weihong Yu, Shuqian Dong, Haina Wang, Jun Qian, Pravina Kota, Jingyun Yan. No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 162B. issue 1. 2013-09-16. PMID:23184535. |
our updated meta- and novel gene-based analyses provide no evidence of the association of bdnf with major depression. |
2013-09-16 |
2023-08-12 |
Not clear |
| Lingli Yang, Zhijun Zhang, Dingming Sun, Zhi Xu, Yonggui Yuan, Xiangrong Zhang, Lingjiang L. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. International journal of geriatric psychiatry. vol 26. issue 5. 2013-09-13. PMID:20845405. |
this study was to test whether serum bdnf or tissue plasminogen activator (tpa) is correlated with the development of depression at the acute stage of stroke. |
2013-09-13 |
2023-08-12 |
Not clear |
| Ritabrata Banerjee, Anup K Ghosh, Balaram Ghosh, Somnath Bhattacharyya, Amal C Monda. Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain. Clinical medicine insights. Pathology. vol 6. 2013-09-13. PMID:24031163. |
there is increasing evidence that brain-derived neurotrophic factor (bdnf) and nerve growth factor (ngf) are involved in the pathophysiology and treatment of depression through binding and activating their cognate receptors trkb and trka respectively. |
2013-09-13 |
2023-08-12 |
human |
| Hussam Jourdi, Mohamed Kabba. Acute BDNF treatment upregulates GluR1-SAP97 and GluR2-GRIP1 interactions: implications for sustained AMPA receptor expression. PloS one. vol 8. issue 2. 2013-09-03. PMID:23460828. |
bdnf treatment acutely regulates ampa receptor expression and function, including synaptic ampar subunit trafficking, and implicates several well defined signaling molecules that are required to elicit long term potentiation and depression (ltp and ltd, respectively). |
2013-09-03 |
2023-08-12 |
Not clear |